Pfizer Whistleblower Case Hangs In The Balance - Judge To Decide: Dismiss or Proceed to Discovery

The ongoing Brook Jackson legal saga continues, as the clinical trial professional and whistleblower spent another day recently in court. On March 2, 2023, in a motion to dismiss the case, a packed courtroom evidenced growing interest in what could be the most important whistleblower case in recent memory. While the judge went on record that he would not decide whether to dismiss or proceed with discovery on that day, Judge Michael Turncale presided over the Qui Tam action for the U.S. Eastern District Court in Beaumont, Texas. This hearing was based on Pfizer’s successful motion to hold off on any discovery pending the motion to dismiss. Consequently, the stakes are big. A decision to dismiss stops this historic proceeding while a decision to continue opens up what could be damaging discovery for the American pharmaceutical company and its co-defendant vendors including ICON, the international clinical research organization (CRO), and Ventavia, the investigator site network that formerly employed Ms. Jackson.
------------------------------------
Join The Conversation! | https://trialsitenews.com/